Epion Therapeutics

Epion Therapeutics

Pharmaceuticals, 1500 District Ave, Burlington, , 1803, Massachusetts, United States, 1-10 Employees

cxlophthalmics.com

  • LinkedIn

phone no Phone Number: +12*********

Who is EPION THERAPEUTICS

Epion Therapeutics is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart, our transform...

Read More

map
  • 1500 District Ave, Burlington, Massachusetts, 1803, United States Headquarters: 1500 District Ave, Burlington, Massachusetts, 1803, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Billion and Over

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 8042 | NAICS Code: 621320 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from EPION THERAPEUTICS

Epion Therapeutics Org Chart and Mapping

Employees

Edward Parsons

Chief Operating Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Epion Therapeutics

Answer: Epion Therapeutics's headquarters are located at 1500 District Ave, Burlington, , 1803, Massachusetts, United States

Answer: Epion Therapeutics's phone number is +12*********

Answer: Epion Therapeutics's official website is https://cxlophthalmics.com

Answer: Epion Therapeutics's revenue is $1 Billion and Over

Answer: Epion Therapeutics's SIC: 8042

Answer: Epion Therapeutics's NAICS: 621320

Answer: Epion Therapeutics has 1-10 employees

Answer: Epion Therapeutics is in Pharmaceuticals

Answer: Epion Therapeutics contact info: Phone number: +12********* Website: https://cxlophthalmics.com

Answer: Epion Therapeutics is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart, our transformative cross-linking system targeting keratoconus, a common type of corneal ectasia, is designed to be minimally invasive with reduced discomfort and a significantly reduced recovery time versus current standards of care. Epion's elegant approach will elevate the standard of care by enabling the treatment of both eyes simultaneously and eliminating the need for further deterioration. With a true epi-on approach that does not disrupt the epithelium, Epion is striving to deliver safer and more accessible vision-preserving care to millions of patients globally.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access